APP and Alzheimer disease: A more indirect action on iron homeostasis via modulation of APP’s C99 fragment would be consistent with the generally later age of AD onset seen for carriers of putative EOfAD mutations in SORL1 compared to carriers of EOfAD mutations in APP [16].